$NSP

Insperity (NSP) Stock Trades Down, Here Is Why

Insperity (NYSE: NSP) shares fell about 7.3% after its Q2 results and full-year guidance. The company reported adjusted EPS above its midpoint, but benefits costs per covered employee rose 5.2% and total gross profit fell 3%. Guidance also pointed to paid worksite employees declining about 1% to 1.6% in 2026.

Original reporting
Published Jul 31, 2026, 7:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Insperity (NSP) Stock Trades Down, Here Is Why — source image
Decision brief

The 30-second read

$NSPBearishMed
01

Why it matters

For traders, the key decision driver is whether the guidance signals durable demand softness and margin compression, or whether the EPS beat and potential normalization in costs can offset the employee decline risk.

02

Market read

A single-stock guidance-driven selloff with concrete operating metrics (cost per covered employee, gross profit) and a 2026 paid worksite employee decline range.

03

What to watch

The piece does not quantify guidance ranges beyond the paid worksite employee decline, nor does it break out whether cost increases are temporary or driven by mix, which could change the interpretation of the guidance.

Relevance 8/10Novelty 6/10Timing: afternoon session selloff after Q2 results and full-year guidance

Background

The article attributes the drop to Q2 results plus full-year guidance, highlighting cost pressure and weaker gross profit alongside a 2026 headcount decline expectation.

Company-level read

Ticker impact

$NSPBearishMedium confidence
Context

Insperity shares fell 7.3% after Q2 results and full-year guidance, with benefits costs up 5.2% and gross profit down 3%.

Expected impact

Near-term downside bias likely persists until investors get clarity on cost trends and worksite employee stabilization.

Evidence & confidence

The article cites specific operating metric deterioration (benefits cost per covered employee, gross profit) plus 2026 paid worksite employee decline guidance, which together can outweigh the adjusted EPS beat.

Market effects

Staffing and HR outsourcing demand is framed as sensitive to economic activity and higher discount rates, reinforcing sector volatility.

No specific regional impact beyond broad risk-off and rates/inflation narrative.

Mentions Brent rising and global bond yields up, which can pressure rate-sensitive service sectors globally.

Counterpoint

The adjusted EPS beat and the article’s note that the move is meaningful but not perception-changing could mean the selloff overstates near-term fundamentals.

Key entities

  • Insperity

    HR outsourcing provider whose Q2 results and full-year guidance triggered a 7.3% afternoon decline.

Related articles

$NSPMed

Insperity (NYSE:NSP) Surprises With Q2 CY2026 Sales

Insperity (NYSE:NSP) reported Q2 CY2026 revenue of $1.69 billion, up 1.7% year over year, beating Wall Street’s revenue estimate by 0.7%. Non-GAAP adjusted EPS was $0.34, up from $0.26, and 6.9% above consensus. The article cites full-year EPS expected to rise from $0.85 to $2.34.

$NSPMed

INSPERITY, INC. (NSP): Results of Operations and Financial Condition

INSPERITY, INC. (NSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Insperity Announces Second Quarter Results HOUSTON – July 29, 2026 – Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today reported results for the second quarter ended June 30, 2026

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.